Use the keywords feature with a free QxMD account.
Use Read by QxMD to access full text via your institution or open access sources.
Read also provides personalized recommendations to keep you up to date in your field.
Existing User
Sign InNew to Read
Sign Up#1
JOURNAL ARTICLE
Danielle K Nagy, Lauren C Bresee, Dean T Eurich, Scot H Simpson
OBJECTIVE: To explore the association between place of residence (metropolitan, urban, rural) and guideline concordant processes of care in the first year of type 2 diabetes management. METHODS: We conducted a retrospective cohort study of new metformin users between April 2015 and March 2020 in Alberta. Outcomes were identified as guideline concordant processes of care through the review of clinical practice guidelines and published literature. Using multivariable logistic regression, the following outcomes were examined by place of residence: dispensation of a statin, angiotensin-converting-enzyme-inhibitor (ACEi) or angiotensin-II-receptor-blocker (ARB), eye examination, and glycated hemoglobin A1C, cholesterol, and kidney function testing...
April 5, 2024: Canadian Journal of Diabetes
#2
REVIEW
Syed Zia Saleem, Areeba Fareed, Syed Muhammad Muneeb Akhtar, Solay Farhat, Amira Mohamed Taha, Aymar Akilimali
BACKGROUND//OBJECTIVE: Diabetes affects millions of people globally, despite treatment options, adherence and other factors pose obstacles. Once-weekly Insulin Icodec, a novel basal Insulin analog with a week-long half-life, offers potential benefits, enhancing convenience, adherence, and quality of life for improved glycemic control. This systematic review and meta-analysis aimed to assess the efficacy and safety of once-weekly Insulin Icodec compared to once-daily Insulin Glargine U-100 in individuals with type II diabetes (T2D)...
April 3, 2024: Diabetology & Metabolic Syndrome
#3
REVIEW
Hadwan Aldahmashi, Della Maneze, Luke Molloy, Yenna Salamonson
BACKGROUND: Complications related to diabetes mellitus impose substantial health and economic burdens to individuals and society. While clinical practice guidelines improve diabetes management in primary care settings, the variability in adherence to these guidelines persist. Hence, there is a need to comprehensively review existing evidence regarding factors influencing nurses' adherence to implementation of clinical practice guidelines to improve clinical care and patient safety. OBJECTIVE: This integrative review seeks to investigate nurses' adherence to clinical guidelines for diabetes management in primary healthcare settings and to explore factors influencing effective implementation, focusing on the role of nurses and impacts on patient outcomes...
March 6, 2024: International Journal of Nursing Studies
#4
JOURNAL ARTICLE
Bushra Anjum, Neeharika Soorneedi, J Swathi, Mohammed Imran, Kavitha Gaddikeri, Anoop Nallapu
AIM: The aim of this work was to determine and compare serum and salivary glucose levels in patients with type II diabetes mellitus (DM). MATERIAL AND METHODS: This study had an overall sample size of 100, which consisted of male and female volunteers aged 30-67 years. Both in-depth interviews and physical tests were conducted. Blood and saliva were collected from the participants while fasting, which were analyzed to determine the levels of salivary alpha-amylase (α-amylase)...
February 2024: Curēus
#5
REVIEW
Fabienne Teysseire, Valentine Bordier, Christoph Beglinger, Bettina K Wölnerhanssen, Anne Christin Meyer-Gerspach
Sugar consumption is known to be associated with a whole range of adverse health effects, including overweight status and type II diabetes mellitus. In 2015, the World Health Organization issued a guideline recommending the reduction of sugar intake. In this context, alternative sweeteners have gained interest as sugar substitutes to achieve this goal without loss of the sweet taste. This review aims to provide an overview of the scientific literature and establish a reference tool for selected conventional sweeteners (sucrose, glucose, and fructose) and alternative sweeteners (sucralose, xylitol, erythritol, and D-allulose), specifically focusing on their important metabolic effects...
February 23, 2024: Nutrients
#6
JOURNAL ARTICLE
Maria Karvela, Caroline T Golden, Nikeysha Bell, Stephanie Martin-Li, Judith Bedzo-Nutakor, Natalie Bosnic, Pierre DeBeaudrap, Sara de Mateo-Lopez, Ahmed Alajrami, Yun Qin, Maria Eze, Tsz-Kin Hon, Javier Simón-Sánchez, Rashmita Sahoo, Jonathan Pearson-Stuttard, Patrick Soon-Shiong, Christofer Toumazou, Nick Oliver
Dietary interventions can reduce progression to type 2 diabetes mellitus (T2DM) in people with non-diabetic hyperglycaemia. In this study we aimed to determine the impact of a DNA-personalised nutrition intervention in people with non-diabetic hyperglycaemia over 26 weeks. ASPIRE-DNA was a pilot study. Participants were randomised into three arms to receive either (i) Control arm: standard care (NICE guidelines) (n = 51), (ii) Intervention arm: DNA-personalised dietary advice (n = 50), or (iii) Exploratory arm: DNA-personalised dietary advice via a self-guided app and wearable device (n = 46)...
March 5, 2024: Scientific Reports
#7
JOURNAL ARTICLE
Mohammad Kermansaravi, Sonja Chiappetta, Chetan Parmar, Scott A Shikora, Gerhard Prager, Teresa LaMasters, Jaime Ponce, Lilian Kow, Abdelrahman Nimeri, Shanu N Kothari, Edo Aarts, Syed Imran Abbas, Ahmad Aly, Ali Aminian, Ahmad Bashir, Estuardo Behrens, Helmuth Billy, Miguel A Carbajo, Benjamin Clapp, Jean-Marc Chevallier, Ricardo V Cohen, Jerome Dargent, Bruno Dillemans, Silvia L Faria, Manoel Galvao Neto, Pierre Y Garneau, Khaled Gawdat, Ashraf Haddad, Mohamad Hayssam ElFawal, Kelvin Higa, Jaques Himpens, Farah Husain, Matthew M Hutter, Kazunori Kasama, Radwan Kassir, Amir Khan, Mousa Khoursheed, Matthew Kroh, Marina S Kurian, Wei-Jei Lee, Ken Loi, Kamal Mahawar, Corrigan L McBride, Hazem Almomani, John Melissas, Karl Miller, Monali Misra, Mario Musella, C Joe Northup, Mary O'Kane, Pavlos K Papasavas, Mariano Palermo, Richard M Peterson, Ralph Peterli, Luis Poggi, Janey S A Pratt, Aayad Alqahtani, Almino C Ramos, Karl Rheinwalt, Rui Ribeiro, Ann M Rogers, Bassem Safadi, Paulina Salminen, Sergio Santoro, Nathaniel Sann, John D Scott, Asim Shabbir, Stephanie Sogg, Erik Stenberg, Michel Suter, Antonio Torres, Surendra Ugale, Ramon Vilallonga, Cunchuan Wang, Rudolf Weiner, Natan Zundel, Luigi Angrisani, Maurizio De Luca
Metabolic and bariatric surgery (MBS) is widely considered the most effective option for treating obesity, a chronic, relapsing, and progressive disease. Recently, the American Society of Metabolic and Bariatric Surgery (ASMBS) and the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) issued new guidelines on the indications for MBS, which have superseded the previous 1991 National Institutes of Health guidelines. The aim of this study is to establish the first set of consensus guidelines for selecting procedures in Class I and II obesity, using an Expert Modified Delphi Method...
February 11, 2024: Scientific Reports
#8
JOURNAL ARTICLE
Rattiyaphon Thaenpramun, Narucha Komolsuradej, Napakkawat Buathong, Siwaluk Srikrajang
Malnutrition is a major problem among older adults with type II diabetes mellitus (T2DM). Some studies suggest that well-glycaemic control increases the risk of frailty due to reduced intake. Therefore, it could be hypothesised that well-glycaemic controlled patients may be at risk of malnutrition. This study aimed to examine, in older adults with T2DM, the association between adequate glycaemic control and malnutrition as well as identify the risk factors for malnutrition. Data includes general characteristics, health status, depression, functional abilities, cognition, and nutrition status were analysed...
January 19, 2024: British Journal of Nutrition
#9
JOURNAL ARTICLE
Ramesh Nadarajah, Peter Ludman, Cécile Laroche, Yolande Appelman, Salvatore Brugaletta, Andrzej Budaj, Hector Bueno, Kurt Huber, Vijay Kunadian, Sergio Leonardi, Maddalena Lettino, Dejan Milasinovic, Ramzi Ajjan, Nikolaus Marx, Chris P Gale
AIM: Diabetes mellitus (diabetes) is common amongst patients with NSTEMI. We describe presentation, care and outcomes of patients admitted with NSTEMI by diabetes status. METHODS: Prospective cohort study including 2928 patients (1104 with prior diabetes, 1824 without) admitted to hospital with NSTEMI from 287 centres in 59 countries. Quality of care was evaluated based on 12 guideline-recommended care interventions. Outcomes included in-hospital acute heart failure, cardiogenic shock, repeat myocardial infarction, stroke/transient ischaemic attack (TIA), BARC Type ≥ 3 bleeding and death, as well as 30-day mortality...
January 8, 2024: European Heart Journal. Quality of Care & Clinical Outcomes
#10
JOURNAL ARTICLE
Omama Tariq, Claire Rosten, Jörg Huber
In Pakistan, type 2 diabetes is widespread, and although dietary recommendations from healthcare professionals are critical to its treatment, cultural norms can have a great influence on the dietary habits of people living with diabetes (PLwD). Understanding the social aspects of the lives of PLwD is crucial when examining the effectiveness of nutritional recommendations and adjustments. This study investigated (1) how PLwD and their family members adjust their nutrition to the recommendations of healthcare professionals to manage type 2 diabetes mellitus (T2DM) and (2) what do PLwD and their family members perceive as enablers and barriers to the necessary nutritional adjustments for managing T2DM...
December 22, 2023: Qualitative Health Research
#11
JOURNAL ARTICLE
Monica Steluta Marc, Daniela Rosca, Felix Bratosin, Ovidiu Fira-Mladinescu, Cristian Oancea, Camelia Corina Pescaru, Diana Velescu, Norbert Wellmann, Alexandru Catalin Motofelea, Ioana Mihaiela Ciuca, Karina Saracin, Diana Manolescu
COVID-19 continues to impact global health systems even after being declared over, with some patients exhibiting severe complications linked to pre-existing conditions. This study aimed to investigate the association between comorbidities, complications, and survival outcomes among COVID-19 survivors in Western Romania. Our hypothesis posited that comorbidities and complications significantly influence survival rates. We conducted a retrospective analysis of 1948 COVID-19 survivors admitted from January to December 2021, with 192 selected for detailed analysis based on inclusion and exclusion criteria...
October 29, 2023: Journal of Personalized Medicine
#12
JOURNAL ARTICLE
Mathias Orellana-Donoso, Michelle López-Chaparro, Marisol Barahona-Vásquez, Andrés Santana-Machuca, Alejandro Bruna-Mejias, Pablo Nova-Baeza, Juan José Valenzuela-Fuenzalida
BACKGROUND: This systematic review explores the most current evidence regarding the mechanisms of neuropathic pain in patients with different types of diabetes and how this pain affects different functional and structural components of the neuroanatomical pain pathways. The review also seeks to provide guidelines for the best approach and treatment for patients experiencing this type of pain. The objective is to determine the effectiveness of alpha-lipoic acid (ALA) in improving functional and symptomatic outcomes in patients with diabetes mellitus type I and type II...
November 3, 2023: Medicine (Baltimore)
#13
JOURNAL ARTICLE
Nonita Thockchom, Mukesh Bairwa, Ravi Kant, Barun Kumar, Yogesh Bahurupi, Bela Goyal
BACKGROUND: Sepsis is one of the leading contributors to global mortality and morbidity, causing multi-organ failure, mainly involving cardiovascular failure, both systolic and diastolic dysfunction, leading to adverse clinical outcomes. There is little clinical data on the correlation with the mortality of patients with type 2 diabetes mellitus (T2DM) with sepsis and septic shock and left ventricular diastolic dysfunction. Our study sought to assess whether the severity of diastolic dysfunction could predict 28-day mortality...
September 2023: Curēus
#14
EDITORIAL
Keegan Dunn, Jonathan Kopel, Mousab Diab, Franklyn Babb
BACKGROUND: Statins are the primary drug used to reduce morbidity and mortality for cardiovascular disease. However, many type II diabetes mellitus (T2DM) patients who are currently not on a statin would otherwise qualify. Therefore, we investigated the proportion of T2DM patients on a statin compared to the total number of T2DM patients eligible to be on a statin. We also examined potential barriers that prevent T2DM patients from being prescribed statins by physicians. METHODS: A retrospective chart study on family medicine patients was collected data on age, race, cholesterol readings, blood pressure, and whether the patient was on blood pressure medications, aspirin, and/or a statin...
2023: Journal of Community Hospital Internal Medicine Perspectives
#15
REVIEW
Vasileios Giannopapas, Lina Palaiodimou, Dimitrios Kitsos, Georgia Papagiannopoulou, Konstantina Stavrogianni, Athanasios Chasiotis, Maria Kosmidou, John S Tzartos, George P Paraskevas, Daphne Bakalidou, Georgios Tsivgoulis, Sotirios Giannopoulos
Introduction : The interactions between Diabetes Mellitus type II (DMII) and Multiple Sclerosis (MS) lead to higher levels of fatigue, higher risk of physical disability, faster cognitive decline, and in general a lower quality of life and a higher frequency of depression compared to the general population. All of the above accelerate the disability progression of patients with MS, reduce the patients' functional capacity, and further increase their psychological and economic burden. Methods : This systematic review and meta-analysis aims to calculate the prevalence of DMII in the MS population...
July 27, 2023: Journal of Clinical Medicine
#16
JOURNAL ARTICLE
Patricia M Wambua, Zahid Khan, Charles M Kariuki, Elijah N Ogola
BACKGROUND: Lipid management after acute myocardial infarction (AMI) is one of the important aspects of secondary prevention in the high cardiovascular (CV) risk group, and targeted reduction of low-density lipoprotein cholesterol (LDL-C) remains the primary target for lipid therapy after myocardial infarction (MI). STUDY OBJECTIVE: To conduct a retrospective study of the adequacy of lipid management in post-MI patients admitted to a tertiary care centre as compared to the 2019 European Society of Cardiology (ESC) guidelines for the management of dyslipidaemia...
July 2023: Curēus
#17
Rebekah Lantz, Waseem Naboulsi, Sarah Yu, Maher Al-Samkari
Polyglandular autoimmune syndrome (PAS) is a rare disorder characterized by the autoimmune destruction of multiple endocrine glands. Type II PAS is the most common of the PAS subtypes and is characterized by Addison's disease, autoimmune thyroid disease, and type I diabetes mellitus. Disease manifestations are predominantly seen in young adulthood with an emerging endocrine disorder; however, a host of other autoimmune conditions can also be present before endocrine organ dysfunction. Due to the complex nature of presentation and management, an important consideration in patient care involves a multidisciplinary team with the addition of an endocrinologist...
July 2023: Curēus
#18
REVIEW
Hany A Zaki, Haris Iftikhar, Nabil A Shallik, Eman Shaban, Nood Dhafi R Al-Marri, Israr Bashir, Awny Elhadad, Fatma Zoghlami, Abeer Abdalrubb
Type II diabetes mellitus (T2DM) is a global epidemic affecting people of all ages in developed and developing countries. The disease is usually characterized by insulin resistance and glucose intolerance; therefore, oral antidiabetic drugs such as thiazolidinediones (TZDs) and biguanide metformin are used to counter these defects. Due to the varied action mechanisms of TZDs and Metformin, their effects on insulin sensitivity and glucose tolerance may differ. Therefore, the current study was carried out to compare the effects of Metformin and TZDs on insulin sensitivity and glucose tolerance among patients with T2DM...
May 2023: Curēus
#19
JOURNAL ARTICLE
Á Cronin, E Noctor, D O' Doherty, S Bowers, E Byrne, A Cremona
OBJECTIVE: Pregnant women with gestational diabetes mellitus (GDM) are 50% more likely to develop type II diabetes (T2D) within 6 months to 2 years after giving birth. Therefore, international guidelines recommend it is best practice for women diagnosed with GDM to attend screening for T2D 6-12 weeks postpartum and every 1-3 years thereafter for life. However, uptake of postpartum screening is suboptimal. This study will explore the facilitators of and barriers to attending postpartum screening for T2D that women experience...
June 6, 2023: Public Health
#20
JOURNAL ARTICLE
Ehsan Nabovati, Fatemeh Rangraz Jeddi, Seyed Mashallah Tabatabaeizadeh, Rahele Hamidi, Reihane Sharif
PURPOSE: Information technology (IT)-based interventions, especially mobile health (mHealth), possess a great potential for promoting self-management in patients with chronic diseases, including diabetes type II. The present study was aimed to design and develop a smartphone-based application (app) for nutrition management in patients with type II diabetes and evaluation of its usability. METHODS: In this study, a three-phase research approach was followed; (1) To determine the information content and functionalities of the app, a five-point Likert scale checklist including six parts was developed based on reviews of clinical practice guidelines and specialized databases...
June 2023: Journal of Diabetes and Metabolic Disorders
Make the most of Read.
Download the mobile app.
Download the mobile app.
Fetching more papers... 
